News & Resources

Olshan Client CorMedix Announces $12 Million IPO

March 25, 2010

Olshan’s client CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, announced the completion of its $12 million IPO. Yehuda Markovits and Kenneth S. Mantel, with assistance from Kenneth A. Schlesinger and Michael D. DeDonato, represented CorMedix.